A Multidisciplinary Guideline to Ensure Best Practice for the Administration of Chemotherapy and Biologic Therapy

2.50
Hdl Handle:
http://hdl.handle.net/10755/165748
Category:
Abstract
Type:
Presentation
Title:
A Multidisciplinary Guideline to Ensure Best Practice for the Administration of Chemotherapy and Biologic Therapy
Author(s):
Eagan, Mary
Author Details:
Mary Eagan, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Abstract:
Safe administration of chemotherapy and biologic therapy requires a defined ordering and order verification process, knowledgeable pharmacists, and specialty trained nurses and physicians to administer the agents. At our NCI-designated comprehensive cancer center, over 300 chemotherapy/biologic therapy agents are administered daily across three sites. An increase in volume, a shift from the inpatient to outpatient setting, and the formulation of a disease team model for the delivery of care prompted a revision of the center's guidelines for the prescribing, preparing, and administration of these agents. A multidisciplinary team of nurses, pharmacists, and physicians reviewed current practice among the disease teams across the center as well as product information, current literature, and documented evidence-based practice. Despite variance among disease teams and settings, consensus was reached for best practice after an extensive clinical review. Agent specific information was developed including common clinical uses, principal adverse effects, the preparation, storage, and stability information, usual doses for administration, clinical considerations, and standard hydration, anti-emetics, and supportive medication orders. This presentation will discuss guideline development, the barriers to standardization, the revisions of the ordering process/form, the implementation process across multiple settings, and the on-going quality assurance and monitoring performed to identify areas for further revisions. The on-line availability and the streamlined revision process made the guidelines attractive to all users, allowing for a safe, supportive administration regimen for all agents and easy access to the most up-to-date information for prescribing, preparing, and administering the agents.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleA Multidisciplinary Guideline to Ensure Best Practice for the Administration of Chemotherapy and Biologic Therapyen_GB
dc.contributor.authorEagan, Maryen_US
dc.author.detailsMary Eagan, Memorial Sloan-Kettering Cancer Center, New York, New York, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/165748-
dc.description.abstractSafe administration of chemotherapy and biologic therapy requires a defined ordering and order verification process, knowledgeable pharmacists, and specialty trained nurses and physicians to administer the agents. At our NCI-designated comprehensive cancer center, over 300 chemotherapy/biologic therapy agents are administered daily across three sites. An increase in volume, a shift from the inpatient to outpatient setting, and the formulation of a disease team model for the delivery of care prompted a revision of the center's guidelines for the prescribing, preparing, and administration of these agents. A multidisciplinary team of nurses, pharmacists, and physicians reviewed current practice among the disease teams across the center as well as product information, current literature, and documented evidence-based practice. Despite variance among disease teams and settings, consensus was reached for best practice after an extensive clinical review. Agent specific information was developed including common clinical uses, principal adverse effects, the preparation, storage, and stability information, usual doses for administration, clinical considerations, and standard hydration, anti-emetics, and supportive medication orders. This presentation will discuss guideline development, the barriers to standardization, the revisions of the ordering process/form, the implementation process across multiple settings, and the on-going quality assurance and monitoring performed to identify areas for further revisions. The on-line availability and the streamlined revision process made the guidelines attractive to all users, allowing for a safe, supportive administration regimen for all agents and easy access to the most up-to-date information for prescribing, preparing, and administering the agents.en_GB
dc.date.available2011-10-27T12:24:12Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:24:12Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.